ABSTRACT It remains a great challenge to explore the facile way to fabricate multi-component nanoparticles in theranostic nanomedicine. Herein, an albumin nanoreactor templated synthesis of theranostic Gd2O3/CuS hybrid nanodots (NDs) has been developed for multimodal imaging guided photothermal tumor ablation. Gd2O3/CuS NDs are found to possess particle size of 4.4 ± 1.1 nm, enhanced longitudinal relaxivity, effective photothermal conversion of 45.5%, as well as remarkable near-infrared fluorescence (NIRF) from Cy7.5-conjugated on albumin corona. The Gd2O3/CuS NDs further exhibited good photostability, enhanced cellular uptake, and preferable tumor accumulation. Thus, the Gd2O3/CuS NDs generate remarkable NIRF imaging and T1-weighted magnetic resonance (MR) imaging, and simultaneously result in effective photothermal tumor ablation upon irradiation. The albumin nanoreactor provides a facile and general strategy to synthesize multifunctional nanoparticles for cancer theranostics.
INTRODUCTION
Nanomedicine provides extraordinary capabilities for cancer diagnostics and therapeutics [1] [2] [3] [4] [5] . The integration of diagnostic imaging and therapy has led to the emergence of theranostic nanoparticles for personalized nanomedicine [6] [7] [8] [9] [10] [11] [12] [13] [14] . A variety of theranostic nanoparticles have been recently developed to provide multifunctional properties for achieving effective cancer imaging and simultaneous therapy through the combination of diagnostic and therapeutic components via co-loading or chemical conjugation [15] [16] [17] . Generally, these nanoparticles frequently suffer from several concerns such as complex compositions and construction, pharmacokinetic inconsistence between imaging and therapeutic agents, as well as the use of clinically unaccepted ingredients. Consequently, it is still a major challenge to develop a facile and rational approach to synthesize high-performance nanoparticles for efficient cancer theranostics.
Recently, some proteins such as albumin, ferritin and aminopeptidase have been extensively explored as biocompatible protein nanoreactors that facilitate the synthesis of metal or metal chalcogenide nanoparticles such as CuS and Ag2S nanodots (NDs) within their intrinsic cavities through the isotropic or anisotropic growth of nanocrystals [18] [19] [20] [21] . The protein nanoreactors possess a satisfactory capacity to achieve a facile construction of ultrasmall nanocrystals with well-defined nanostructures in a mild condition [22] . However, a few efforts have been made to generate multi-component nanoparticles through simultaneous multiple reactions within protein nanoreactor for cancer theranostics. Herein, we developed a facile approach to synthesize Gd2O3/CuS hybrid NDs through two precipitation reactions within albumin nanoreactor, leading to multimodal imaging-guided photothermal tumor ablation (Fig. 1) . gadolinium(III) chloride (GdCl3) were added into 10.0 mL of 50.0 mg mL −1 bovine serum albumin (BSA) under vigorous stirring. Next, NaOH was used to adjust the pH of the solution to 12. Then, 0.8 mL of 100 mmol L −1 Na2S was added into the mixture. The mixture was further stirred at 55°C for another 4 h, followed by the formation of Gd2O3/CuS NDs. The obtained suspension was centrifuged through the ultrafiltration (100 kDa, Millipore) and purified through the dialysis against distilled water for 24 h. To conjugate Cy7.5 with Gd2O3/CuS NDs, 1.0 mL of Cy7.5-NHS (0.5 mg mL −1 ) was mixed with 4.0 mL suspension under stirring in dark overnight to allow the amide reaction between activated carboxyl of Cy7.5 and amine of albumin, followed by the dialysis against distilled water to obtain Cy7.5 conjugated NDs. Different Gd/Cu feed molar ratios at 0.05:1, 0.1:1, 0.25:1, 0.5:1, 1:1 and 2:1 were used in the preparation procedures to obtain hybrid NDs of varied Gd/Cu ratios.
Characterization
Transmission electron microscopy (TEM, Hitachi H-600) was used to observe the morphology of the nanoparticles. The hydrodynamic diameter was measured using dynamic light scattering (DLS, Zetasizer NanoZS90). The absorption spectra of Gd2O3/CuS NDs were measured using a UV-vis spectrophotometer (Shimadzu UV2600). Inductively coupled plasma optical emission spectrometer (ICP-OES, VARIAN 710-ES) was applied to quantify the concentrations of Cu and Gd.
Photothermal effect
All light irradiation was conducted using a laser at 785 nm (1.5 W cm −2 ). To study the photothermal effects of Gd2O3/CuS NDs, 0.5 mL Gd2O3/CuS NDs at various Cu concentrations ranging from 0.1 to 2.0 mmol L −1 were irradiated for 5 min. The temperature of the solutions was monitored using a digital temperature sensor at an interval of 30 s. The temperature elevation (ΔT) was used to evaluate the photothermal effects. To evaluate the photothermal conversion efficiency, Gd2O3/CuS NDs at the concentration of 2.0 mmol L −1 Cu were irradiated for 12 min, and then the laser was removed for cooling the sample to room temperature. During this process, the temperature of the solution was recorded using a thermometer at an interval of 30 s. To evaluate the photostability, the absorbance at 785 nm was measured under irradiation for different time. To evaluate the ability to maintain the temperature elevations, 0.5 mL Gd2O3/CuS NDs at the concentration of 0.5 mmol L −1 Cu are subjected to 5 min irradiation (light ON), and then was cooled to room temperature in the absence of irradiation (light OFF), followed by another 4 light ON/OFF cycles.
Cellular uptake
Gd2O3/CuS NDs at the concentration of 0.1 mmol L −1 Cu were incubated with 4T1 tumor cells (1.0 × 10 5 cells per well) for 6 h and 24 h, respectively. Then, the cells were treated with trypsin for 3 min at 37°C, followed by cell counting. Afterwards, the cells were digested by nitric acid, and the concentrations of Cu and Gd were measured using ICP-OES, respectively.
Cytotoxicity
The cytotoxicity of Gd2O3/CuS NDs under irradiation or not was investigated using MTT assay. 100 μL Gd2O3/CuS NDs at various concentrations were incubated with 4T1 tumor cells (5000 cells per well) for 24 h. Then, the cells were rinsed and supplied with 100 μL fresh media, followed by 1.5 W cm −2 irradiation at 785 nm for 3 min or not. After another 24 h incubation, the cell viability was evaluated using MTT assay.
Reviewer Committees of Soochow University for Animal Use and Welfare. Cy7.5-labelled Gd2O3/CuS NDs (Cy7.5-Gd2O3/CuS NDs) were intravenously injected into the 4T1 tumor-bearing nude mice at the dose of 75.0 μmol kg −1 (n=3) Cu. Then, the in vivo fluorescence imaging was performed at 0, 1, 2, 4, 6, 24, 48, and 168 h post-injection using IVIS Lumina II imaging system, respectively. Finally, the average fluorescent intensity at tumor region was calculated.
Magnetic resonance (MR) imaging
For in vivo MR imaging, Gd2O3/CuS NDs (75.0 μmol kg −1 Gd) were intravenously injected into the 4T1 tumor-bearing BALB/c mice. Then, T1-weight images were obtained at different time using a 1.5 T MR imaging system (Philips, Achieva) with a fat-saturated 3D gradient echo imaging sequence (TR/TE = 400/10 ms, 256×256 matrices, slices = 3, thickness = 2 mm, averages = 4, FOV = 60×60). 
Photothermal antitumor efficacy

RESULTS AND DISCUSSION
Gd2O3/CuS NDs were constructed using albumin as a nanoreactor under a mild condition in water. Gadolinium(III) and copper(II) ions were firstly added to the aqueous solution of BSA for binding with abundant amino acid residues. Then, the pH of the solution was further adjusted to 12, leading to the formation of unfolded BSA with hollow nanocages [23, 24] . Afterwards, Gd 3+ bound with albumin reacted with OH¯to generate Gd2O3 nanocrystals, and Na2S was also added to react with copper ions for generating CuS nanocrystals in the nanoreactor. Thus, the Gd2O3/CuS NDs were synthesized in albumin nanoreactor. Cy7.5 was conjugated with amino groups on albumin as an NIRF agent to achieve the fabrication of Cy7.5-Gd2O3/CuS NDs (Fig. 1a) .
The morphology of the obtained Gd2O3/CuS NDs was characterized using TEM, indicating 4.4 ± 1.1 nm in diameter with a uniform distribution (Fig. 2a) . DLS measure- ment indicates that the Gd2O3/CuS NDs have a hydrodynamic diameter of 18.2 ± 2.2 nm owing to the presence of protein corona, implying a potential passive targeting capability through enhanced permeation and retention (EPR) effect (Fig. 2b) . The UV-vis absorption spectrum of the Gd2O3/CuS NDs in water displayed a strong and board absorbance in the near infrared (NIR) region from 700 to 1300 nm, possibly resulting from the presence of CuS (Fig. 2c) . A thin film of Gd2O3/CuS NDs on the glass silde was prepared to avoid the strong absorbance of water, and the absorption spectrum was obtained at the range of 400-2400 nm (Fig. S1) . The results suggested the strong localized surface plasmon resonance (LSPR) peak at~1460 nm from CuS nanocrystals, confirming the NIR light triggered potent photothermal effect. Several small peaks from 1800 to 2400 nm could be attributed to the absorbance of BSA, demonstrating the presence of albumin in the nanocomposites. The X-ray diffraction (XRD (Fig. S2) .
Given that Gd2O3 is a component with longitudinal relaxivity [25] [26] [27] [28] [29] , the longitudinal proton relaxation time (T1) of Gd2O3/CuS NDs was measured using T1-weighted mapping at the magnetic field of 1.5 T for calculating their relaxivities (Fig. S3) . The Gd/Cu molar ratios of the resulted Gd2O3/CuS NDs were measured to be 0.04:1, 0.06:1, 0.15:1, 0.30:1, 0.60:1 and 1.20:1 at various Gd/Cu feed molar ratios, respectively. Remarkably, Gd/Cu molar ratio had distinct influence on their relaxivity, indicating a gradual decrease from 50.3 to 27.2 L mmol −1 s −1 along with the increase of Gd/Cu ratio in the NDs (Fig. 2d and Fig. S4 ), probably due to geometrical confinement of gadolinium in the restricted space of albumin cavity, which influences the paramagnetic behavior of the Gd 3+ ions [25, 30] . Nevertheless, the Gd2O3/CuS NDs exhibited relaxivity of about 9-17-fold as compared to Gd-DTPA (3.2 L mmol −1 s −1 ), indicating a superior relaxivity for potential MRI. To balance the dosing concentration of Gd2O3 and CuS, the Gd/Cu molar ratio of 1.20:1 was selected for subsequent studies.
To evaluate the photothermal effect, temperature elevation of the Gd2O3/CuS NDs at various Cu concentrations was evaluated under 1.5 W cm −2 irradiation at 785 nm (Fig.  2e) . The Gd2O3/CuS NDs exhibited a fast temperature elevation of 9.9°C at a relatively low concentration of 0.1 mmol L −1 , displaying a distinct photothermal effect. Remarkably, the Gd2O3/CuS NDs displayed a concentration-dependent temperature elevation, which is highly important for causing potent photo-induced hyperthermia (>45°C) [31] . Subsequently, the Gd2O3/CuS NDs were further found to have a photothermal conversion efficiency of~45.5% (Fig. S5) , which is much higher than that of the extensively studied photothermal agents such as Au nanorods (Au NRs,~13%) [32] .
The stability of Gd2O3/CuS NDs under NIR light irradiation was evaluated using temperature monitoring. The Gd2O3/CuS NDs were subjected to 785 nm irradiation at 1.5 W cm −2 for 5 min (light ON). Then, the irradiation was removed and the Gd2O3/CuS NDs were cooled to room temperature in the absence of irradiation (light OFF). This procedure was further repeated for another four light ON/OFF cycles. The Gd2O3/CuS NDs exhibited tremendous temperature increase of 35.0°C after first irradiation, and no significant change of temperature elevation was observed during the subsequent four cycles (Fig. 2f) . In contrast, Au NRs displayed a significant temperature decrease after laser ON/OFF cycles, as well as obvious decrease of NIR absorbance compared with the Gd2O3/CuS NDs (Fig. S6) . Moreover, the Gd2O3/CuS NDs also showed no remarkable change in the absorbance at 785 nm under continuous 15 min irradiation, further confirming that these NDs have ideal photostability (Fig. S7) . It indicates that the Gd2O3/CuS NDs have good photostability to maintain effective light treatment for theranostics.
To evaluate the cellular uptake, the Gd2O3/CuS NDs were incubated with 4T1 tumor cells for 6 and 24 h, respectively. The Gd2O3/CuS NDs exhibited time-dependent cellular uptakes of Cu and Gd (Fig. 3a and Fig. S8a) . Additionally, the endocytic pathway of the Gd2O3/CuS NDs was also evaluated using different pathway inhibitors (Fig. 3b and Fig. S8b ), indicating that they have a clathrin-mediated endocytic pathway that is also energy-dependent. To investigate the intracellular distribution, the Cy7.5-Gd2O3/CuS NDs were incubated with 4T1 cells stained with Lysotracker Green DND-26 and Hoechst 33342 for 2 h, followed by observation using confocal laser scanning microscopy (CLSM). The Cy7.5-Gd2O3/CuS NDs in red fluorescence exhibited a co-localization percentage of 98% with the lysosomes in green fluorescence, indicating a preferable distribution into lysosomes through clathrin-mediated endocytosis (Fig. 3c) . Afterwards, the photo-induced cytotoxicity of Gd2O3/CuS NDs was further carried out against 4T1 tumor cells for 24 h, followed by 3 min irradiation (785 nm, 1.5 W cm −2 ). the Gd2O3/CuS NDs showed negligible cell damage (IC50, 318 μmol L −1 ) with the absence of irradiation, implying the desirable biocompatibility of Gd2O3/CuS NDs in dark. Conversely, the Gd2O3/CuS NDs exhibited severe cell injury (IC50, 111 μmol L −1 ) with concentration-dependent behavior under irradiation (Fig.  3d) , probably owing to the concentration-dependent photothermal effects and effective cellular uptake. Remarkably, the Gd2O3/CuS NDs exhibit an ideal ability to produce photothermal damage against tumor cells with great potential for in vivo photothermal therapy (PTT).
The pharmacokinetic behavior of the Gd2O3/CuS NDs was investigated on healthy Balb/c mice by monitoring of Gd concentration in the blood plasma. The results exhibited an elimination half-life time (t1/2β) of 1.58 h (Fig. S9 , Table S1 ). The biodistribution behavior of the Gd2O3/CuS NDs was further evaluated at 24 h post-injection (Fig. S10) . Gd2O3/CuS NDs exhibited a primary distribution at tumor during 24 h, probably owing to their significant EPR effect. To demonstrate the multimodal imaging capacity of Cy7.5-Gd2O3/CuS NDs, the in vivo NIRF imaging was carried out on the mice bearing 4T1 tumors. The release profile study of Cy7.5 from the Cy7.5-Gd2O3/CuS NDs showed only a slight release during 24 h in the physiological conditions, indicating the preferable stability of conjugated Cy7.5 in the NDs (Fig. S11) . Interestingly, the Cy7.5-Gd2O3/CuS NDs exhibited obvious NIRF signals at tumor during 7 days (Fig. 4a, b) , suggesting that these NDs have an effective NIRF imaging capacity with good sensitivity. In addition, it also shows that the Cy7.5-Gd2O3/CuS NDs resulted in a long-time retention of NIRF signals at tumor, implying their good retention behavior at tumor for flexible PTT treatment. Moreover, MR imaging of the Gd2O3/CuS NDs was further studied on the mice bearing 4T1 tumor. As shown in Fig. 4c, d , the MR intensity at tumor sites injected with hybrid NDs showed significant enhancement at 2, 12 and 24 h post-injection, while Gd-DTPA as a control had no obvious influence on the MR intensity at tumor sites, suggesting a remarkable contrast-enhanced MRI capacity of Gd2O3/CuS NDs to provide an imaging modality with high spatial resolution.
To demonstrate the in vivo hyperthermia of Gd2O3/CuS NDs, the mice bearing 4T1 tumor were treated with NDs at different doses through a single-dose injection, followed by 5 min irradiation (785 nm, 1.5 W cm −2 ), and then their infrared thermographs were captured using a thermal imaging camera (Fig. 5a) . The calculated temperature profiles show that Gd2O3/CuS at the dose of 25.0 μmol kg −1 Cu resulted in the temperature elevation of 11.1°C at the tumor under irradiation (Fig. 5b) , suggesting a remarkable hyperthermia even at a relatively low dosage. Importantly, higher temperature elevations of 14.1°C and 19.9°C at the tumors were achieved at the doses of 50.0 and 75.0 μmol kg −1 Cu under irradiation, respectively, suggesting a dose-dependent hyperthermia. Possibly, both high photothermal conversion efficiency and enhanced tumor accumulation contribute to superior hyperthermia at tumor, which is able to facilitate in vivo PTT treatment.
The in vivo photothermal anticancer efficacy of the Gd2O3/CuS NDs was evaluated using 4T1 tumor-bearing mice at various doses through a single-dose intravenous administration, followed by 785 nm irradiation for 5 min (Fig.  5c, d ). Phosphate buffered saline (PBS) caused~23-fold increase of tumor volume as compared to their original volumes with or without irradiation, confirming that the growth of tumor is not significantly affected by the light irradiation itself. A similar tumor growth behavior was observed for the Gd2O3/CuS NDs at the highest dose of 75.0 μmol kg −1 without irradiation, indicating that they had no influence on the tumor growth in the absence of irradiation. Interestingly, the Gd2O3/CuS NDs at the doses of 25.0 and 50.0 μmol kg −1 Cu resulted in rapid tumor ablation upon irradiation, but displayed remarkable tumor regrowth after~10 day post-irradiation. Most importantly, the Gd2O3/CuS NDs at 75 μmol kg −1 Cu exhibited complete tumor ablation without any regrowth, implying that the tumor temperature elevation of~19.9°C effectively results in the total tumor ablation without any regrowth. Distinctly, the good photostability, high photothermal conversion efficiency, and preferable tumor accumulation of Gd2O3/CuS NDs synergistically contribute to the desirable anticancer efficacy.
Hematoxylin & eosin (H&E) staining of tumor sections from mice with various treatments was carried out to validate the photothermal damage (Fig. S12) . Severe hemorrhagic inflammation and destructive cell necrosis could be found at the tumor of mice treated with Gd2O3/CuS NDs at 6 h post-irradiation. In contrast, PBS and Gd2O3/CuS NDs without irradiation exhibited no remarkable cell damage. Additionally, no noticeable influence on major tissues such as heart, liver, spleen, lung and kidney was observed (Fig.  S12) .
CONCLUSIONS
In summary, we demonstrated a facile synthesis of Gd2O3/CuS hybrid NDs through the albumin nanoreactor for NIRF/MR imaging and simultaneous photothermal tumor ablation. The Gd/Cu ratios can be tuned in the NDs for favorable longitudinal relaxivity, resulting in significant enhanced MR imaging with spatial resolution. The Gd2O3/CuS NDs can be easily conjugated with Cy7.5 for further NIRF imaging with good sensitivity, facilitating their complementary NIRF/MR imaging. The Gd2O3/CuS NDs also possessed good photostability, high photothermal conversion efficiency, as well as enhanced cellular uptake and tumor accumulation, thereby facilitating precise tumor ablation upon irradiation. Our albumin nanoreactor boosts a facile and universal approach to develop versatile nanomaterials for cancer theranostics.
